AIM ImmunoTech
30 hedge funds and large institutions have $3.01M invested in AIM ImmunoTech in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
47% more capital invested
Capital invested by funds: $2.05M → $3.01M (+$959K)
3% less funds holding
Funds holding: 31 → 30 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.6K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
+$17.9K |
| 3 |
Jane Street
New York
|
+$10.7K |
| 4 |
DBRC
D.B. Root & Company
Pittsburgh,
Pennsylvania
|
+$5.84K |
| 5 |
Renaissance Technologies
New York
|
+$4.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$84.5K |
| 2 |
BlackRock
New York
|
-$52.9K |
| 3 |
Rockefeller Capital Management
New York
|
-$17K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.9K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $502 | – | – | – |
|
|
CFGS
27
Concourse Financial Group Securities
Birmingham,
Alabama
| $335 | – | – | – |
|
|
TWC
28
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $150 | – | – | – |
|
|
HNB
29
Huntington National Bank
Columbus,
Ohio
| $38 | – | – | – |
|
30
UBS Group
Zurich,
Switzerland
| $9 | – | – | – |
|
31
JP Morgan Chase
New York
| $2 | – | – | – |
|
|
NA
32
NewEdge Advisors
New Orleans,
Louisiana
| $1 | – | – | – |
|
|
33
Rockefeller Capital Management
New York
| – | -$17K | -400 | Closed |
|
|
34
Citadel Advisors
Miami,
Florida
| – | -$12.9K | -300 | Closed |
|
|
35
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$9K | -204 | Closed |
|
36
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$9K | -203 | Closed |
|
|
SC
37
Stephens Consulting
Flint,
Michigan
| – | -$645 | -15 | Closed |
|
|
CCMI
38
Creative Capital Management Investments
San Diego,
California
| – | -$86 | -2 | Closed |
|
|
NMG
39
New Millennium Group
Sandy,
Utah
| – | -$14 | – | – |
|
40
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$145 | +3 | New |
|
AIM Hedge Fund Activity: Q2 2023 in Review
30 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2023, worth a combined $3.01M — up 47% from $2.05M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of AIM and 5 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $21.6K. The largest seller was Morgan Stanley, cutting an estimated $84.5K.
- 30 institutional investors held AIM ImmunoTech (AIM) as of Q2 2023, down from 31 in Q1 2023.
- Funds reported $3.01M of AIM ImmunoTech stock for Q2 2023, up 47% quarter-over-quarter.
- 5 funds opened new AIM ImmunoTech positions in Q2 2023 and 6 closed out, a net change of -1 holder.
- The largest AIM ImmunoTech buyer in Q2 2023 was Susquehanna International Group, an estimated $21.6K added.
- The largest AIM ImmunoTech seller in Q2 2023 was Morgan Stanley, an estimated $84.5K sold.
Based on aggregated 13F filings for Q2 2023.